Evidence map›Paper›PMID 40208553›Full record

ReviewArchives of pharmacal research2025

A review on bacteria-derived antioxidant metabolites: their production, purification, characterization, potential applications, and limitations.

Nazli Pinar Arslan, Fakhrul Azad, Tugba Orak, Aysenur Budak-Savas, Serkan Ortucu, Pranav Dawar, Mustafa Ozkan Baltaci, Hakan Ozkan, Nevzat Esim, Mesut Taskin

Abstract readReview
In one paragraph

Review in Archives of pharmacal research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. A Novel Indigoidine-like NRPS Gene fromAntioxidants (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Harnessing the seaweed holobiont: antibacterial and antioxidant lead compounds from epiphytic microbiota.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  7. Marine-DerivedInternational journal of molecular sciences · 2026
    Review
  8. Article
  9. Review
  10. 3,6'-Disinapoyl Sucrose fromAntioxidants (Basel, Switzerland) · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nazli Pinar ArslanVocational School of Health Services, Bingol University, Bingol, Turkey.
Fakhrul AzadDepartment of Biochemistry and Cell Biology, Chobanian and Avedisian School of Medicine, Boston University, Boston, MA, USA.
Tugba OrakDepartment of Molecular Biology and Genetics, Science Faculty, Ataturk University, 25240, Erzurum, Turkey.
Aysenur Budak-SavasDepartment of Medical Pharmacology, Faculty of Medicine, Ataturk University, Erzurum, Turkey.
Serkan OrtucuDepartment of Molecular Biology and Genetics, Science Faculty, Erzurum Technical University, Erzurum, Turkey.
Pranav DawarEnvironmental Molecular Sciences Laboratory (EMSL), Pacific Northwest National Laboratory (PNNL), Richland, WA, USA.
Mustafa Ozkan BaltaciDepartment of Molecular Biology and Genetics, Science Faculty, Ataturk University, 25240, Erzurum, Turkey.
Hakan OzkanDepartment of Molecular Biology and Genetics, Science Faculty, Ataturk University, 25240, Erzurum, Turkey.
Nevzat EsimDepartment of Molecular Biology and Genetics, Science and Art Faculty, Bingol University, Bingol, Turkey.
Mesut TaskinDepartment of Molecular Biology and Genetics, Science Faculty, Ataturk University, 25240, Erzurum, Turkey. mesut.taskin@atauni.edu.tr.ORCID http://orcid.org/0000-0002-9350-9628

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antioxidants are organic molecules that scavenge reactive oxygen species (ROS) and reactive nitrogen species (RNS), thereby maintaining cellular redox balance in living organisms. The human body synthesizes endogenous antioxidants, whereas humans obtain exogenous antioxidants from other organisms such as plants, animals, fungi, and bacteria. This review primarily focuses on the antioxidant potential of natural metabolites and extracts from five major bacterial phyla, including the well-studied Actinobacteria and Cyanobacteria, as well as less-studied Bacteroides, Firmicutes, and Proteobacteria. The literature survey revealed that the metabolites and the extracts with antioxidant activity can be obtained from bacterial cells and their culture supernatants. The metabolites with antioxidant activity include pigments, phycobiliproteins, polysaccharides, mycosporins-like amino acids, peptides, phenolic compounds, and alkaloids. Both metabolites and extracts demonstrate in vitro antioxidant capacity through radical-scavenging, metal-reducing, and metal-chelating activity assays. In in vivo models, they can scavenge ROS and RNS directly and/or indirectly eliminate them by enhancing the activities of antioxidant enzymes, such as catalase, superoxide dismutase, and glutathione peroxidase. Due to their antioxidant activities, they may find applications in the cosmetic industry as anti-aging agents for the skin and in medicine as drugs or supplements for combating oxidative stress-related disorders, such as neurodegenerative diseases and diabetes. The literature survey also elucidated that some metabolites and extracts with antioxidant activity also exhibited strong antimicrobial properties. Therefore, we consider that they may have future applications in the treatment of infectious diseases, the preparation of pathogen-free healthy foods, and the extension of food shelf life.

Indexed as

AntioxidantsBacteriaBiological ProductsAnimalsHumansOxidative StressReactive Oxygen SpeciesAntioxidantsBiological ProductsReactive Oxygen SpeciesActinobacteriaCyanobacteriaExogenous antioxidantsNatural metabolitesOxidative stressProteobacteria

Identifiers

PMID40208553
PMCPMC12058845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.